BlackRock Funds IV - BlackRock Health Sciencs Oppor Port Fd USD Cls R
Name
As of 03/15/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
$67.37
$9.49 B
0.00%
$0.00
1.44%
Vitals
YTD Return
6.3%
1 yr return
17.0%
3 Yr Avg Return
5.1%
5 Yr Avg Return
9.4%
Net Assets
$9.49 B
Holdings in Top 10
41.5%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.44%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 19.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$100
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 03/15/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
$67.37
$9.49 B
0.00%
$0.00
1.44%
BHSRX - Profile
Distributions
- YTD Total Return 6.3%
- 3 Yr Annualized Total Return 5.1%
- 5 Yr Annualized Total Return 9.4%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.37%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameBlackRock Funds IV - BlackRock Health Sciencs Oppor Port Fd USD Cls R
-
Fund Family NameBlackRock
-
Inception DateSep 12, 2011
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerErin Xie
Fund Description
BHSRX - Performance
Return Ranking - Trailing
Period | BHSRX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 6.3% | -13.3% | 20.7% | 40.49% |
1 Yr | 17.0% | -19.1% | 38.0% | 40.49% |
3 Yr | 5.1%* | -31.4% | 13.8% | 33.33% |
5 Yr | 9.4%* | -3.8% | 14.2% | 30.88% |
10 Yr | 9.3%* | -0.7% | 13.8% | 32.71% |
* Annualized
Return Ranking - Calendar
Period | BHSRX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -0.6% | -12.6% | 19.0% | 72.39% |
2022 | -13.1% | -53.9% | 3.2% | 55.13% |
2021 | 1.8% | -39.6% | 24.2% | 41.03% |
2020 | 14.2% | -13.6% | 178.2% | 49.01% |
2019 | 20.2% | 3.8% | 63.8% | 56.30% |
Total Return Ranking - Trailing
Period | BHSRX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 6.3% | -13.3% | 20.7% | 40.49% |
1 Yr | 17.0% | -19.1% | 38.0% | 40.49% |
3 Yr | 5.1%* | -31.4% | 13.8% | 33.33% |
5 Yr | 9.4%* | -3.8% | 14.2% | 30.88% |
10 Yr | 9.3%* | -0.7% | 13.8% | 32.71% |
* Annualized
Total Return Ranking - Calendar
Period | BHSRX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 3.2% | -12.6% | 19.0% | 66.87% |
2022 | -6.3% | -53.9% | 3.7% | 28.85% |
2021 | 11.4% | -33.9% | 26.0% | 39.10% |
2020 | 19.1% | -0.7% | 180.6% | 62.25% |
2019 | 24.9% | 4.6% | 63.8% | 58.52% |
NAV & Total Return History
BHSRX - Holdings
Concentration Analysis
BHSRX | Category Low | Category High | BHSRX % Rank | |
---|---|---|---|---|
Net Assets | 9.49 B | 6.16 M | 45 B | 5.52% |
Number of Holdings | 150 | 23 | 413 | 9.82% |
Net Assets in Top 10 | 4.17 B | 2.07 M | 20.4 B | 6.75% |
Weighting of Top 10 | 41.45% | 18.1% | 77.0% | 80.98% |
Top 10 Holdings
- UnitedHealth Group Inc 9.44%
- Johnson & Johnson 4.46%
- Eli Lilly and Co 4.02%
- Thermo Fisher Scientific Inc 3.94%
- Pfizer Inc 3.79%
- Abbott Laboratories 3.45%
- AbbVie Inc 3.26%
- Cigna Corp 3.09%
- Danaher Corp 3.05%
- Medtronic PLC 2.98%
Asset Allocation
Weighting | Return Low | Return High | BHSRX % Rank | |
---|---|---|---|---|
Stocks | 96.90% | 87.17% | 106.13% | 59.51% |
Cash | 2.30% | 0.00% | 32.99% | 47.85% |
Other | 0.80% | -22.99% | 17.73% | 16.56% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 85.28% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 81.01% |
Bonds | 0.00% | 0.00% | 12.39% | 83.44% |
Stock Sector Breakdown
Weighting | Return Low | Return High | BHSRX % Rank | |
---|---|---|---|---|
Healthcare | 98.96% | 59.26% | 100.00% | 79.11% |
Basic Materials | 0.73% | 0.00% | 7.16% | 18.99% |
Financial Services | 0.31% | 0.00% | 1.60% | 9.49% |
Utilities | 0.00% | 0.00% | 0.00% | 80.38% |
Technology | 0.00% | 0.00% | 22.69% | 82.91% |
Real Estate | 0.00% | 0.00% | 5.89% | 82.28% |
Industrials | 0.00% | 0.00% | 7.02% | 82.91% |
Energy | 0.00% | 0.00% | 0.00% | 80.38% |
Communication Services | 0.00% | 0.00% | 9.11% | 80.38% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 84.18% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 81.65% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | BHSRX % Rank | |
---|---|---|---|---|
US | 90.61% | 66.21% | 104.41% | 60.12% |
Non US | 6.29% | 0.00% | 29.78% | 38.65% |
BHSRX - Expenses
Operational Fees
BHSRX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.44% | 0.08% | 4.28% | 33.13% |
Management Fee | 0.67% | 0.03% | 1.25% | 48.47% |
12b-1 Fee | 0.50% | 0.00% | 1.00% | 70.51% |
Administrative Fee | 0.07% | 0.03% | 0.25% | 21.05% |
Sales Fees
BHSRX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
BHSRX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
BHSRX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 19.00% | 0.00% | 238.00% | 17.39% |
BHSRX - Distributions
Dividend Yield Analysis
BHSRX | Category Low | Category High | BHSRX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 6.98% | 88.96% |
Dividend Distribution Analysis
BHSRX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annual | SemiAnnual | Annual |
Net Income Ratio Analysis
BHSRX | Category Low | Category High | BHSRX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.37% | -2.54% | 1.85% | 63.46% |
Capital Gain Distribution Analysis
BHSRX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Dec 09, 2022 | $0.022 | OrdinaryDividend |
Dec 08, 2022 | $0.022 | OrdinaryDividend |
Dec 06, 2019 | $2.314 | OrdinaryDividend |
Dec 05, 2019 | $0.051 | OrdinaryDividend |
Dec 13, 2012 | $0.025 | OrdinaryDividend |
BHSRX - Fund Manager Analysis
Managers
Erin Xie
Start Date
Tenure
Tenure Rank
Jul 31, 2003
18.85
18.9%
Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.
Xiang Liu
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.
Jeff Lee
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2011. Mr. Lee began his investment career in 2006 and has a BA from Princeton University
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.84 | 0.25 |